Clinical Trial Update: XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicating an early-phase study of XNW27011 for multiple advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Adenocarcinoma

Drugs mentioned

• XNW27011

Snippet

Sponsor: Evopoint Biosciences Inc. | Conditions: Pancreatic Adenocarcinoma Metastatic, Lung Cancer (NSCLC) | Phase 1, Phase 2 | Status: RECRUITING